27524 Federal Register / Vol. 66, No. 96 / Thursday, May 17, 2001 / Notices

MSC 2220, Bethesda, MD 20892, 301–496–

2075.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Information is also available on the

Institute’s/Center’s home page:

www.nih.gov/fic/about/advisory.html, where

an agenda and any additional information for

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.106, Minority International

Research Training Grant in the Biomedical

and Behavioral Sciences; 93.154, Special

International Postdoctoral Research Program

in Acquired Immunodeficiency Syndrome;

93.168, International Cooperative

Biodiversity Groups Program; 93.934, Fogarty

International Research Collaboration Award;

93.989, Senior International Fellowship

Awards Program, National Institutes of

Health, HHS)

Dated: May 10, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–12463 Filed 5–16–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Complementary

and Alternative Medicine; Notice of

Meeting

Pursuant to Section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the Cancer Advisory

Panel for Complementary and

Alternative Medicine (CAPCAM).

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: Cancer Advisory

Panel for Complementary and Alternative

Medicine.

Date: May 21, 2001.

Open: May 21, 2001, 9:00 am to

adjournment.

Agenda: The agenda will include a report

on clinical trial data on Virulizen (R), an

update on the Rand BSC Approach to BCS,

an update on NIH initiatives for CAM and

Cancer treatments, and other business of the

Panel.

Place: Pooks Hill Marriott, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Richard Nahin, Ph.D.,

Executive Secretary, National Center for

Complementary and Alternative Medicine,

National Institutes of Health, 6707

Democracy Blvd, Suite 106, Bethesda, MD

20892, 301/496–7801.

The public comments session is scheduled

on May 21 from 3:00 pm to 3:30 pm. Each

speaker will be permitted 5 minutes for their

presentation. Interested individuals and

representatives of organizations are requested

to notify Dr. Richard Nahin, National Center

for Complementary and Alternative

Medicine, NIH, 6707 Democracy Blvd, Suite

106, Bethesda, Maryland 20892, 301–496–

7801, Fax 301–480–3621. Letters of intent to

present comments, along with a brief

description of the organization represented,

should be received no later than 5:00 pm

May 15, 2001. Only one representative of an

organization may present oral comments.

Any person attending the meeting who does

not request an opportunity to speak in

advance of the meeting may be considered

for oral presentation, if time permits, and at

the discretion of the Chairperson. In

addition, written comments may be

submitted to Dr. Nahin at the address listed

above up to ten calendar days (May 31, 2001)

following the meeting.

Copies of the meeting agenda and the

roster of members will be furnished upon

request by Dr. Richard Nahin, Executive

Secretary, CAPCAM, National Institutes of

Health, 6707 Democracy Blvd, Suite 106,

Bethesda, Maryland 20892, 301 496–7801,

Fax 301–480–3621.

This meeting is being published less than

15 days prior to the meeting due to

scheduling conflicts.

Dated: May 9, 2001.

Anna Snouffer,

Acting Director, Office of Federal Advisory

Committee Policy, NIH.

[FR Doc. 01–12469 Filed 5–16–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Eye Institute; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Board of Scientific Counselors, National

Eye Institute.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting. The meeting

will be closed to the public as indicated

below in accordance with the provisions

set forth in section 552b(c)(6), Title 5

U.S.C., as amended for the review,

discussion, and evaluation of individual

intramural programs and projects

conducted by the NATIONAL EYE

INSTITUTE, including consideration of

personnel qualifications and

performance, and the competence of

individual investigators, the disclosure

of which would constitute a clearly

unwarranted invasion of personal

privacy.

Name of Committee: Board of Scientific

Counselors, National Eye Institute,

Date: June 4–5, 2001.

Open: June 4, 2001, 9 a.m. to 10 a.m.

Agenda: Opening remarks by the Director,

Intramural Research Program, on matters

concerning the intramural program of the

NEI.

Place: National Institutes of Health, 9000

Rockville Pike, Building 10, Room 10B16,

Bethesda, MD 20892.

Closed: June 4, 2001, 10 a.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: National Institutes of Health, 9000

Rockville Pike, Building 10, Room 10B16,

Bethesda, MD 20892.

Closed: June 5, 2001, 9 a.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: National Institutes of Health, 9000

Rockville Pike, Building 10, Room 10B16,

Bethesda, MD 20892.

Contact Person: Robert B. Nussenblatt, MD,

Director, Intramural Research Program,

National Eye Institute, National Institutes of

Health, PHS, DHHS, Bethesda, MD 20892,

301–496–3123.

Information is also available on the

Institute’s/Center’s home page:

www.nei.nih.gov, where an agenda and any

additional information for the meeting will

be posted when available.

(Catalogue of Federal Domestic Assistance

Program No. 93.867, Vision Research,

National Institutes of Health, HHS)

Dated: May 10, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–12458 Filed 5–16–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Human Genome Research

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,